The bactericidal activities of ampicillin and vancomycin against 40 recent isolates of Enterococcusfaecalis were examined by kill-kinetic studies at concentrations of 4 x the MIC and 20 pg/ml. Greater killing was seen with ampicillin (3.57 ± 0.87 and 2.50 ± 1.09 log10 CFU/ml, respectively, mean t standard deviation) than with vancomycin (1.23 ± 0.65 and 1.05 + 0.57 log1o CFU/ml, respectively). Highly gentamicin-resistant strains showed a tendency toward reduced susceptibility to killing; beta-hemolytic strains were more susceptible than nonhemolytic strains when exposed to ampicillin at 20 ,ug/ml. Within each group, individual isolates demonstrated great variability in susceptibility to killing by the drugs.
In recent years, enterococcal isolates demonstrating highlevel resistance to both streptomycin and gentamicin, conditions that preclude synergistic interactions between cell wall-active antibiotics and available aminoglycosides, have become common in many centers (5, 6) . Against such isolates, there is no other combination of antimicrobial agents which reliably provides bactericidal activity. As a result, treatment with a cell wall-active agent alone, usually ampicillin or vancomycin, would emerge as the most logical alternative for antimicrobial therapy in serious infections caused by such organisms (1, 11) . Although relative tolerance to killing by 1-lactams is considered a characteristic of enterococci, it is clear that some variability exists among naturally occurring isolates of Enterococcusfaecalis in their susceptibilities to the bactericidal effects of these agents (3, 7, 9, 15) . Using time-kill curves, we examined the susceptibilities of 40 unique strains of E. faecalis to killing by ampicillin or vancomycin; half of the strains demonstrated high-level gentamicin resistance. Because of suggestions that patients with bloodstream infections caused by betahemolytic, gentamicin-resistant enterococci fare less well than do those with bloodstream infections caused by nonhemolytic strains (8), we also examined the influence of hemolysis properties on susceptibility to killing by the antimicrobial agents.
We selected 40 recently isolated, unique strains of E. faecalis, with 10 strains belonging to each of the following groups: non-beta-hemolytic and non-high-level gentamicin resistant, non-beta-hemolytic and high-level gentamicin resistant, beta-hemolytic and non-high-level gentamicin resistant, and beta-hemolytic and high-level gentamicin resistant. Thirty-four strains were chosen from 345 enterococci collected at our hospital in 1990 and 1991. Six strains referred from four other institutions between 1985 and 1990 were added to fill the complement of beta-hemolytic strains. One isolate was known to produce 1-lactamase. Beta The bactericidal activities of ampicillin and vancomycin were determined by previously described methods in glucose phosphate-citrate broth by using inocula of 106 CFU/ml (2, 14) . For each drug, two concentrations were selected for testing on the basis of their achievable levels in serum: 20 ,g/ml and 4x the MIC for the strain (4 or 8 ,ug/ml); sulbactam was added to ampicillin (1:2) when testing the 3-lactamase-producing strain. Colony counts as low as 1.3 log1o CFU/ml could be detected. Preliminary experiments excluded significant vancomycin carryover, because lowinoculum bacterial suspensions (10 to 1,000 CFU) prepared in the presence or absence of vancomycin at 4 and 8 ,ug/ml yielded identical growth (<5% difference) when plated onto antibiotic-free agar. Ampicillin was eliminated by the addition of excess penicillinase (BBL) at the moment of sampling. The magnitudes of bactericidal effects were compared by the Mann-Whitney U test.
The MICs of both ampicillin and vancomycin ranged from 1 to 2 pg/ml. No significant differences were observed in the MICs determined in the two media. Twenty isolates were highly resistant to gentamicin (MIC, >500 p.g/ml). Figure 1 demonstrates the bactericidal activities of ampicillin at 4x the MIC and 20 ,g/ml against the 40 isolates. Results for vancomycin at these concentrations are shown in Fig. 2 . The higher concentration of ampicillin (20 ,g/ml) was less effective in killing than was the 4x MIC at all sampling points from 8 to 48 h (0.001 < P < 0.037). Considering individual isolates, the bactericidal activity of the drug at the higher concentration at 24 h exceeded that of the drug at the lower concentration against only 7 of the 40 isolates, all of which were beta-hemolytic. The paradoxical bactericidal effect noted with ampicillin was not seen with vancomycin. The bactericidal activity of ampicillin exceeded that of vancomycin at either concentration of the drugs ( Fig. 1 and 2 CFU/ml) and 20 ,ug/ml (2.50 + 1.09 log1o CFU/ml) was significantly greater (P < 0.001) than that which occurred with the corresponding concentrations of vancomycin (1.23 ± 0.65 and 1.05 ± 0.57 log1o CFU/ml, respectively).
For both ampicillin and vancomycin, the magnitude of bactericidal effects against individual strains varied over a wide range (Fig. 3) . For two non-high-level gentamicinresistant isolates which showed the greatest susceptibility to killing by ampicillin, when subinhibitory concentrations of gentamicin were combined with ampicillin, substantially greater rates of killing were noted over the first 8 h compared with the rates with ampicillin alone (data not shown).
To assess the reproducibility of killing as measured by this method, several strains were repeatedly tested with exposure to ampicillin (20 ,ug/ml). Two 
